急性早幼粒细胞白血病药物治疗进展
被引量:2
Progress of pharmic therapy for acute promyelocytic leukemia
摘要
随着对急性早幼粒细胞白血病(APL)发病机制研究的深入,APL的药物治疗取得很大的进展,特别是诱导APL细胞分化和调亡药物的研究和应用,使APL患者的完全缓解率和无病生存期明显提高。
出处
《国外医学(肿瘤学分册)》
2005年第11期875-878,共4页
Foreign Medical Sciences (Cancer Section)
参考文献15
-
1Zhang JW, Wang JY, Chen SJ, et al. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. J Biosci ,2000,25 ( 3 ) :275-284.
-
2So CW, Dong S, So CK, et al. The impact of differential binding of wide-type RARalpha, PML-, PLZF-and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acide responses in acute promyelocytic leukemia. Leukemia, 2000,14 ( 1 ):77-83.
-
3Pendiuo F, Flexor M, Delhommeau F, et al. Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukemia. Proc Natl Acad Sci USA,2001,98(12) :6662-6667.
-
4Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol,2001,38( 1 ) :13-25.
-
5Cai X, Shen YL, Zhu Q, et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmemnbrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia, 2000,14 ( 2 ): 262 -270.
-
6Di Noto R, Boccuni P, Costantini S, et al. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family. Tissue Antigens. 1999,54(6) :597-602.
-
7Gianni M, Koken MH, Chelbi-Alix MK, et al. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistent NB4 cells. Blood, 1998,91 ( 11 ) :4300-4310.
-
8Petti MC, Fazi F, Gentile M, et al. Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia:in vitro and in vivo studies . Blood, 2002, 100 (3):1065-1067.
-
9Cote S, Rosenauer A, Bianchini A, ct al. Response to histonc deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid- resistent APL cells. Blood,2002,100 ( 7 ) :2586-2596.
-
10梁勇,羊裔明,袁淑兰,孟文彤,刘霆,贾永前.丹参酮ⅡA诱导早幼粒细胞白血病细胞分化及其分子机制研究[J].中华血液学杂志,2000,21(1):23-26. 被引量:63
二级参考文献6
-
1傅兴生,徐燕兰,魏宝秀,潘凌云.卵巢上皮性肿瘤细胞DNA含量流式细胞仪分析[J].中华病理学杂志,1994,23(1):50-50. 被引量:5
-
2Pandolfi PP. In vivo analysis of the molecular genetics of acute promyelocytic leukemia. Oncogen, 2001, 20:5726-5735.
-
3Neus V,Dolirs C,Marata A,et al. Rapid diagnosis of acutepromyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3. Am J Clin Pathol, 2000,114: 786-792.
-
4Nadia I,Gerarc B, Maria A, et al. Granulocytic differetiation of human NBs promyelocytic leukemia cells induced by ATRA metabolites. Cancer Res, 2001, 61: 700-705.
-
5Dmitri N, Gerd GM. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest funetions of a nuclear depot. Oncogene, 2001,20: 7234-7242.
-
6张玉五,高亚菲.活血化淤药丹参抗肿瘤作用研究进展[J].西安医科大学学报,1990,11(2):191-192. 被引量:25
共引文献64
-
1张雁,于庆生.丹参的抗肿瘤作用[J].安徽中医学院学报,2007,26(6):61-62. 被引量:7
-
2唐仲萍,黄秀梅.浅谈两种天然药物的抗肿瘤作用[J].青海医药杂志,2008,38(5):77-80.
-
3柳丽,张洪泉.丹参活性成分的现代中药药理研究进展[J].中国野生植物资源,2003,22(6):1-4. 被引量:85
-
4吉布强,王素兰,景本年.复方丹参注射液治疗急性白血病的研究[J].现代中西医结合杂志,2004,13(22):2958-2959. 被引量:2
-
5王文明,刘兰平,谭生建.丹参制剂中丹参酮ⅡA测定方法的研究进展[J].中成药,2004,26(11):934-936. 被引量:6
-
6邹夏慧,张焜和.中药抗肿瘤作用的分子机制研究进展[J].国外医学(中医中药分册),2004,26(6):330-334. 被引量:7
-
7梁勇,宋文秀,王珺,井丽萍,瞿文,付蓉,吴咸中.丹参酮ⅡA诱导耐维甲酸的急性早幼粒细胞白血病细胞分化及其机制[J].中华内科杂志,2005,44(5):366-369. 被引量:14
-
8刘世成,朱艳,王如建,胡小鹰.丹参酮ⅡA含量测定和抗肿瘤作用的研究进展[J].黑龙江中医药,2005,34(4):62-63. 被引量:6
-
9梁雪,孔佩艳.急性早幼粒细胞白血病发生机制及治疗研究进展[J].第三军医大学学报,2005,27(17):1807-1809. 被引量:4
-
10梁勇,井丽萍,王珺,宋文秀,付蓉,瞿文,吴咸中.丹参酮ⅡA对初治、复发及耐药人急性早幼粒细胞白血病细胞体外诱导分化作用[J].中华血液学杂志,2006,27(1):62-63. 被引量:4
同被引文献12
-
1赵维莅,陈赛娟.砷剂治疗白血病-人类肿瘤靶向治疗的新模式[J].中华医学杂志,2005,85(7):439-440. 被引量:5
-
2司玉玲,庞华,王英娟,赵玲娣.复方青黛片治疗复发急性早幼粒细胞白血病的临床研究[J].广西医学,2005,27(3):372-373. 被引量:2
-
3时新颖,潘登,郑顶运,黄明.复方青黛、ATRA与化疗交替治疗缓解后急性早幼粒细胞白血病[J].蚌埠医学院学报,2005,30(4):317-318. 被引量:3
-
4左翠娥,张建,李栋,张关生.序贯综合疗法治疗急性早幼粒细胞白血病26例[J].白血病.淋巴瘤,2006,15(1):59-61. 被引量:4
-
5李新,赵耀中,李增军,李云涛,李妍,万长春,李桥川,邓书会,杨仁池,韩明哲,邱录贵.急性早幼粒细胞白血病170例长期生存分析[J].中国实验血液学杂志,2006,14(3):437-441. 被引量:18
-
6季鸥,陆化.急性白血病出血与血小板计数的相关性研究进展[J].白血病.淋巴瘤,2006,15(6):471-474. 被引量:3
-
7Elaine S.Jaffe,Nancy Lee Harris,Harald Stein,et al,周小鸽译.世界卫生组织肿瘤分类及诊断标准系列-造血与淋巴组织肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:315-318.
-
8陈灏珠.实用内科学[M],11版,北京:人民卫生出版社,2003:1785,
-
9Sanz MA,Fenaux P,Lo Coco F,et al.Arsenic trioxide in the treatment of acute promyelocytic leukemia:A review of current evidence[J].Haematologica,2005,90(9):1231.
-
10吴天勤,蒋复高,仇红霞,沈红石,王网珍,钱雅静,秦龙梅.急性早幼粒细胞白血病完全缓解后巩固治疗方案的初步探讨[J].中华内科杂志,2002,41(10):701-703. 被引量:12
引证文献2
-
1陆进,查庆桂,苗忠,周广政,王骏.复方黄黛片、全反式维A酸及化疗序贯治疗缓解后急性早幼粒细胞白血病临床观察[J].吉林医学,2007,28(17):1848-1850. 被引量:3
-
2汪元河,黄映康,龙义国,王杰.急性白血病脑出血死亡法医学鉴定1例[J].贵阳医学院学报,2009,34(3):352-353.
二级引证文献3
-
1陈诚,吴永忠,胥尹,陈晓品.全反式维甲酸对人肺腺癌A549细胞放射敏感性的影响[J].重庆医科大学学报,2012,37(5):413-417. 被引量:2
-
2范长生,何敏媚,吴久鸿.复方黄黛片治疗急性早幼粒细胞白血病预算影响分析[J].中国新药杂志,2017,26(10):1219-1224. 被引量:9
-
3张锁林.口服维A酸片联合复方黄黛片治疗非高危急性早幼粒细胞白血病的临床疗效分析[J].世界复合医学,2021,7(1):147-149.
-
1吴文成.垂体瘤的药物治疗进展[J].国外医学(内分泌学分册),1990,10(2):72-75.
-
2王晖,刘心.多发性骨髓瘤的发病机制及药物治疗进展[J].国际病理科学与临床杂志,2006,26(5):403-406. 被引量:6
-
3罗思红.慢性髓细胞白血病的药物治疗进展[J].北方药学,2013,10(8):49-49.
-
4黄健(综述),王晓稼(审校).晚期乳腺癌分子靶向药物治疗进展[J].国际肿瘤学杂志,2008,35(3):189-192.
-
5张庆利.化疗所致胃肠道反应的药物治疗进展[J].中国社区医师,2002,18(8):8-8.
-
6闫志华.乳腺癌的药物治疗进展[J].山西医药杂志,2007,36(8):720-722.
-
7王兵(综述),于甬华(审校).胆道系统癌药物治疗进展[J].国际肿瘤学杂志,2009,36(8):619-621.
-
8黄镜.晚期食管癌的药物治疗进展[J].中国临床研究,2010,23(1):1-4. 被引量:7
-
9贾臻,胡夕春.乳腺癌的药物治疗进展[J].世界临床药物,2011,32(8):511-512. 被引量:3
-
10龚新雷,秦叔逵.胰腺癌的药物治疗进展[J].临床肿瘤学杂志,2007,12(1):68-76. 被引量:8